Abstract
Sarcomas are mesenchymal tumors that represent 1% of malignant diseases in humans. Of these, 4–10% occur in the head and neck and only <1% occur in the larynx.1 These groups of neoplasms have a wide range of histological variants and, accordingly, their clinical behavior varies widely, from slow-growing, relatively circumscribed tumors, to rapidly growing, locally invasive malignancies. In addition, the heterogeneity of the location of the laryngeal anatomic sub-sites require special therapeutic considerations.2, The most common non-epithelial tumor is chondrosarcoma, which represents 0.5% of laryngeal tumors.3
This article is protected by copyright. All rights reserved.
http://ift.tt/2oXFEtl
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου